recently reported the GLP-1 analogue liraglutide ameliorates MG-induced cytotoxicity and apoptosis in human neuroblastoma cell SH-SY5Y through enhanced expression of pro-survival Mcl1 signaling protein, activation of Akt, MEK1/2, and transcription factor p90RSK 12
Aging of the immune system is associated with reduced immune responsiveness 1
7 Potential side effects
In the SURPASS clinical trials, the particularly potent GLP-1 RAs, tirzepatide, at a 15 mg dose administered for 40 weeks, resulted in more than half of the patients achieving an HbA1c level below 5.7%, which falls within the normal glycemic range
Contact your GP or diabetes care team for assessment
"You cant be 100% clear on what the pens contain, and whether the contents are what you think they are, posing a risk of potential harmful substances," she explained